Mirum Pharmaceuticals, Inc. (MIRM)
97.95
+2.09
(+2.18%)
USD |
NASDAQ |
Apr 17, 16:00
97.98
+0.03
(+0.03%)
After-Hours: 20:00
Mirum Pharmaceuticals SG&A Expense (Quarterly) : 74.13M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | 158.08M |
| BioMarin Pharmaceutical, Inc. | 446.21M |
| Insmed, Inc. | 212.48M |
| Ionis Pharmaceuticals, Inc. | 130.00M |
| Cogent Biosciences, Inc. | 23.93M |